Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
Holding CMMB?
Track your performance easily

Chemomab Therapeutics (CMMB) Financial Statements

219 Followers

Chemomab Therapeutics Financial Overview

Chemomab Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.137; its P/E ratio is -1.63; Chemomab Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue-----
Gross Profit--$ -5.14M--
EBIT-$ -9.05M$ -8.05M$ -8.08M$ -6.73M
EBITDA-$ -9.03M$ -8.03M$ -8.06M$ -6.72M
Net Income Common Stockholders-$ -8.75M$ -8.27M$ -8.08M$ -6.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.78M$ 20.77M$ 13.52M$ 10.74M$ 9.88M
Total Assets$ 22.15M$ 35.01M$ 43.06M$ 50.22M$ 56.38M
Total Debt$ 392.00K$ 177.00K$ 214.00K$ 244.00K$ 280.00K
Net Debt$ -19.39M$ -20.59M$ -13.30M$ -10.50M$ -9.60M
Total Liabilities$ 5.15M$ 7.06M$ 6.84M$ 5.59M$ 4.54M
Stockholders Equity$ 17.00M$ 27.95M$ 36.22M$ 44.62M$ 51.84M
Cash Flow-
Free Cash Flow-$ -7.19M$ -5.70M$ -5.30M$ -5.71M
Operating Cash Flow-$ -7.19M$ -5.70M$ -5.25M$ -5.70M
Investing Cash Flow-$ 14.43M$ 9.35M$ 6.07M$ 1.73M
Financing Cash Flow--$ -869.00K$ 39.00K$ 22.00K
Currency in USD

Chemomab Therapeutics Earnings and Revenue History

Chemomab Therapeutics Debt to Assets

Chemomab Therapeutics Cash Flow

Chemomab Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis